People | October 05, 2023
Emmes appoints Matt Bond as CFO
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Advances clinical research capabilities with leading regulatory grade registries platform
Subscribe To Our Newsletter & Stay Updated
